Brain Regions Involved in Fatigue Sensation: Reduced Acetylcarnitine Uptake into the Brain

Fatigue is an indispensable sense for ordering rest. However, the neuronal and molecular mechanisms of fatigue remain unclear. Chronic fatigue syndrome (CFS) with long-lasting fatigue sensation seems to be a good model for studying these mechanisms underlying fatigue sensation. Recently, we found that most patients with CFS showed a low level of serum acetylcarnitine, which well correlated with the rating score of fatigue, and that a considerable amount of acetyl moiety of serum acetylcarnitine is taken up into the brain. Here we show by metabolite analysis of the mouse brain that an acetyl moiety taken up into the brain through acetylcarnitine is mainly utilized for the biosynthesis of glutamate. When we studied the cerebral uptake of acetylcarnitine by using [2-(11)C]acetyl-L-carnitine in 8 patients with CFS and in 8 normal age- and sex-matched controls, a significant decrease was found in several regions of the brains of the patient group, namely, in the prefrontal (Brodmann's area 9/46d) and temporal (BA21 and 41) cortices, anterior cingulate (BA24 and 33), and cerebellum. These findings suggest that the levels of biosynthesis of neurotransmitters through acetylcarnitine might be reduced in some brain regions of chronic fatigue patients and that this abnormality might be one of the keys to unveiling the mechanisms of the chronic fatigue sensation.

[1]  M. Raichle,et al.  Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  D. Costa,et al.  Brainstem perfusion is impaired in chronic fatigue syndrome. , 1995, QJM : monthly journal of the Association of Physicians.

[3]  M. Schmidt,et al.  The distribution and role of carnitine in the mammalian brain. , 1982, Life sciences.

[4]  Kouzi Yamaguti,et al.  Acylcarnitine and Chronic Fatigue Syndrome , 1997 .

[5]  T Machii,et al.  Acylcarnitine metabolism during fasting and after refeeding. , 1996, Biochemical and biophysical research communications.

[6]  O Nickel,et al.  Regional cerebral blood flow in depression: associations with psychopathology. , 1989, Journal of affective disorders.

[7]  E. Meyer Simultaneous correction for tracer arrival delay and dispersion in CBF measurements by the H215O autoradiographic method and dynamic PET. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  T. Greitz,et al.  A computerized brain atlas: construction, anatomical content, and some applications. , 1991, Journal of computer assisted tomography.

[9]  R Cluydts,et al.  Comparison of 99m Tc HMPAO SPECT scan between chronic fatigue syndrome, major depression and healthy controls: an exploratory study of clinical correlates of regional cerebral blood flow. , 1996, Neuropsychobiology.

[10]  M. Raichle,et al.  Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.

[11]  R. Fariello,et al.  Systemic acetyl-L-carnitine elevates nigral levels of glutathione and GABA. , 1988, Life sciences.

[12]  R. Dolan,et al.  Changes in regional cerebral blood flow on recovery from depression , 1995, Psychological Medicine.

[13]  Karl J. Friston,et al.  Tests for Distributed, Nonfocal Brain Activations , 1995, NeuroImage.

[14]  Karl J. Friston,et al.  Assessing the significance of focal activations using their spatial extent , 1994, Human brain mapping.

[15]  B. Långström,et al.  Synthesis of O-[11C]Acetyl CoA, O-[11C]Acetyl-L-carnitine, and L-[11C]carnitine labelled in specific positions, applied in PET studies on rhesus monkey. , 1997, Nuclear medicine and biology.

[16]  W. Ammann,et al.  Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue , 1997, Neurology.

[17]  F A Jolesz,et al.  Detection of intracranial abnormalities in patients with chronic fatigue syndrome: comparison of MR imaging and SPECT. , 1994, AJR. American journal of roentgenology.

[18]  Filippo Conti,et al.  Effect of acetyl-l-carnitine on recovery of brain phosphorus metabolites and lactic acid level during reperfusion after cerebral ischemia in the rat — study by 13P- and 1H-NMR spectroscopy , 1994, Brain Research.

[19]  J K Kelleher,et al.  Role of Acetyl‐l‐Carnitine in Rat Brain Lipogenesis: Implications for Polyunsaturated Fatty Acid Biosynthesis , 1998, Journal of neurochemistry.

[20]  G. Forloni,et al.  Neuroprotective activity of acetyl‐L‐carnitine: Studies in vitro , 1994, Journal of neuroscience research.

[21]  U. Tirelli,et al.  Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. , 1998, The American journal of medicine.

[22]  C. Roe,et al.  Maternal and fetal tissue distribution of L-carnitine in pregnant mice: low accumulation in the brain. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[23]  William E. Klunk,et al.  Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease , 1995, Neurobiology of Aging.

[24]  P. Fox,et al.  Cingulate function in depression: a potential predictor of treatment response , 1997, Neuroreport.

[25]  Stefano Calzolari,et al.  Effect of acetyl-l-carnitine on hyperactivity and spatial memory deficits of rats exposed to neonatal anoxia , 1997, Neuroscience Letters.

[26]  G Fiskum,et al.  Neuroprotective effects of acetyl-L-carnitine after stroke in rats. , 1997, Annals of emergency medicine.

[27]  T Machii,et al.  High uptake of [2-11C]acetyl-L-carnitine into the brain: a PET study. , 1997, Biochemical and biophysical research communications.

[28]  M Freedman,et al.  Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome. , 1992, Nuclear medicine communications.

[29]  T. Robbins,et al.  The prefrontal cortex: Executive and cognitive functions. , 1998 .

[30]  Luciano Angelucci,et al.  Effect of acetyl-l-carnitine chronic treatment on discrimination models in aged rats , 1988, Physiology & Behavior.

[31]  H. Misaki,et al.  Acylcarnitine deficiency in chronic fatigue syndrome. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  T Machii,et al.  Low levels of serum acylcarnitine in chronic fatigue syndrome and chronic hepatitis type C, but not seen in other diseases. , 1998, International journal of molecular medicine.

[33]  H. Onoe,et al.  Brain Networks Affected by Synchronized Sleep Visualized by Positron Emission Tomography , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  V. Ganapathy,et al.  Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. , 1999, The Journal of pharmacology and experimental therapeutics.

[35]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.

[36]  I. Galynker,et al.  Hypofrontality and negative symptoms in major depressive disorder. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  L L Bieber,et al.  Entry of acetyl-L-carnitine into biosynthetic pathways. , 1986, Biochimica et biophysica acta.

[38]  Karl J. Friston,et al.  The anatomy of melancholia – focal abnormalities of cerebral blood flow in major depression , 1992, Psychological Medicine.